124 related articles for article (PubMed ID: 26886433)
1. Patient-provider communication with HIV-positive women about abnormal Pap test results.
Wigfall LT; Bynum SA; Friedman DB; Brandt HM; Richter DL; Glover SH; Hébert JR
Women Health; 2017 Jan; 57(1):19-39. PubMed ID: 26886433
[TBL] [Abstract][Full Text] [Related]
2. Cervical Cancer Prevention Knowledge and Abnormal Pap Test Experiences Among Women Living with HIV/AIDS.
Wigfall LT; Bynum SA; Brandt HM; Friedman DB; Bond SM; Lazenby GB; Richter DL; Glover SH; Hébert JR
J Cancer Educ; 2015 Jun; 30(2):213-9. PubMed ID: 24928481
[TBL] [Abstract][Full Text] [Related]
3. Differences in cervical cancer screening and follow-up for black and white women in the United States.
Ford S; Tarraf W; Williams KP; Roman LA; Leach R
Gynecol Oncol; 2021 Feb; 160(2):369-374. PubMed ID: 33323276
[TBL] [Abstract][Full Text] [Related]
4. Assessment of factors impacting cervical cancer screening among low-income women living with HIV-AIDS.
Ogunwale AN; Coleman MA; Sangi-Haghpeykar H; Valverde I; Montealegre J; Jibaja-Weiss M; Anderson ML
AIDS Care; 2016; 28(4):491-4. PubMed ID: 26493859
[TBL] [Abstract][Full Text] [Related]
5. Social and Structural Determinants of Cervical Health among Women Engaged in HIV Care.
Bynum SA; Wigfall LT; Brandt HM; Julious CH; Glover SH; Hébert JR
AIDS Behav; 2016 Sep; 20(9):2101-9. PubMed ID: 26955821
[TBL] [Abstract][Full Text] [Related]
6. HPV knowledge, screening barriers and facilitators, and sources of health information among women living with HIV: perspectives from the DC community during the COVID-19 pandemic.
Ciceron AC; Jeon MJ; Monroe AK; Clausen ME; Magnus M; Le D
BMC Womens Health; 2022 Apr; 22(1):110. PubMed ID: 35397535
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
Açikgöz A; Ergör G
Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
[TBL] [Abstract][Full Text] [Related]
8. How Is Health Literacy Related to Pap Testing Among US Women?
Thompson EL; Wheldon CW; Vamos CA; Griner SB; Daley EM
J Cancer Educ; 2019 Aug; 34(4):789-795. PubMed ID: 29931455
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
10. Confusion about Pap smears: lack of knowledge among high-risk women.
Daley E; Perrin K; Vamos C; Hernandez N; Anstey E; Baker E; Kolar S; Ebbert J
J Womens Health (Larchmt); 2013 Jan; 22(1):67-74. PubMed ID: 23215902
[TBL] [Abstract][Full Text] [Related]
11. Health literacy as a predictor of follow-up after an abnormal Pap smear: a prospective study.
Lindau ST; Basu A; Leitsch SA
J Gen Intern Med; 2006 Aug; 21(8):829-34. PubMed ID: 16881942
[TBL] [Abstract][Full Text] [Related]
12. Pap test adherence, cervical cancer perceptions, and HPV knowledge among HIV-infected women in a community health setting.
Lambert CC; Chandler R; McMillan S; Kromrey J; Johnson-Mallard V; Kurtyka D
J Assoc Nurses AIDS Care; 2015; 26(3):271-80. PubMed ID: 25769754
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the body mass index and abnormal pap smears.
Prompakay R; Promthet S; Kamsa-Ard S; Suwanrungruang K; Wiangnon S; Bradshaw P
Asian Pac J Cancer Prev; 2013; 14(9):5503-6. PubMed ID: 24175849
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer screening after 50: near extinction?
Abdullah NN; Daud S; Al-Kubaisy W; Saari IS; Saad SR
Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():136-140. PubMed ID: 27693934
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of abnormal Pap smears among young women co-infected with HIV in rural South Africa - implications for cervical cancer screening policies in high HIV prevalence populations.
Gaym A; Mashego M; Kharsany AB; Walldorf J; Frohlich J; Karim QA
S Afr Med J; 2007 Feb; 97(2):120-3. PubMed ID: 17404673
[TBL] [Abstract][Full Text] [Related]
16. Breast and cervical cancer screening utilization among Hispanic women living near the United States-Mexico border.
Nuño T; Castle PE; Harris R; Estrada A; García F;
J Womens Health (Larchmt); 2011 May; 20(5):685-93. PubMed ID: 21428792
[TBL] [Abstract][Full Text] [Related]
17. Recency of Pap testing and future testing plans among women aged 18-64: analysis of the 2007 Health Information National Trends Survey.
Ashok M; Berkowitz Z; Hawkins NA; Tangka F; Saraiya M
J Womens Health (Larchmt); 2012 Jul; 21(7):705-12. PubMed ID: 22480224
[TBL] [Abstract][Full Text] [Related]
18. Screening for cervical cancer in HIV-infected women receiving care in the United States.
Stein MD; Cunningham WE; Nakazono T; Turner BJ; Andersen RM; Bozzette SA; Shapiro MF;
J Acquir Immune Defic Syndr; 2001 Aug; 27(5):463-6. PubMed ID: 11511823
[TBL] [Abstract][Full Text] [Related]
19. Breast and cervical cancer screening in obese minority women.
Ferrante JM; Chen PH; Jacobs A
J Womens Health (Larchmt); 2006 Jun; 15(5):531-41. PubMed ID: 16796480
[TBL] [Abstract][Full Text] [Related]
20. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility.
Soccio J; Brown M; Comino E; Friesen E
J Adv Nurs; 2015 Dec; 71(12):2858-66. PubMed ID: 26279461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
